Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and
Key facts
- Who runs it
- Third People's Hospital, Huzhou City, Zhejiang Province, China
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 78 people enrolled
- Started
- 13 Oct 2023
- Ended
- 19 Sept 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- the conventional treatment group
- the ACT group
- Record updated
- 24 June 2025
- Why it stopped
- the sponsor has determined that access to the full dataset is no longer available
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- (1)Meets the diagnostic criteria for schizophrenia as defined in the International Classification of Diseases, Tenth Revision (ICD-10)
- (2) age > 60 years
- (3)possesses at least a primary school education, enabling independent completion of all questionnaires
- (4) has been taking antipsychotic medication continuously and regularly for at least one year during the enrollment period, with current symptoms and disease status stabilized in the maintenance phase
- (5)informed consent obtained from the patient or their family/guardian
Who cannot take part
- (4) receipt of electroconvulsive therapy within the past three months
- (1) Coexisting organic mental disorders, affective disorders, or similar conditions
- (2) coexisting physical illnesses that may affect cognitive function, such as hepatic or renal dysfunction
- (3) alcohol dependence or dependence on psychoactive substances
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
ACT combined with stratified intervention improved cognitive function and quality of life in elderly schizophrenia patients by enhancing psychological flexibility and family support.
The 2 groups in the trial
- the conventional treatment groupOther group
Patients received conventional mental health education once weekly for 6 weeks, covering schizophrenia symptoms, treatment, and prognosis. Standard nursing care and antipsychotic medications (e.g., olanzapine, quetiapine) were maintained without additional psychological interventions.
- the ACT groupOther group
Patients received ACT-based nursing interventions tailored to risk factors (e.g., age ≥70, long disease duration), including: ACT modules: Acceptance, cognitive defusion, mindfulness, values clarification, and committed action. Adjunct strategies: Family therapy, Tai Chi, and crisis planning. Frequency: Daily practice + 1-2 group sessions/week for 6 weeks. Goal: Enhance psychological flexibility, reduce stigma, and improve cognitive function.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and the Application Effect of Acceptance and Commitment Therapy Nursing Model
- Record updated
- 24 June 2025